Home
About
Overview
Sharing Data
ORCID
Help
History (3)
High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors.
Pulling Back the Curtain on Deprescribing Interventions.
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S, Shaughnessy J, Ram S, Rice PA. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine. Front Immunol. 2019; 10:321.
View in:
PubMed
subject areas
Animals
Bacterial Vaccines
Complement System Proteins
Epitopes
Gonorrhea
Humans
Lipopolysaccharides
Neisseria gonorrhoeae
Peptides
authors with profiles
Peter A Rice MD
Sanjay Ram MD
Jutamas Shaughnessy MD, PhD